The mechanism of antimalarial action of the ruthenium(II)–chloroquine complex [RuCl2(CQ)]2

The mechanism of antimalarial action of the ruthenium-chloroquine complex [RuCl(2)(CQ)](2) (1), previously shown by us to be active in vitro against CQ-resistant strains of Plasmodium falciparum and in vivo against P. berghei, has been investigated. The complex is rapidly hydrolyzed in aqueous solution to [RuCl(OH(2))(3)(CQ)](2)[Cl](2), which is probably the active species. This compound binds to hematin in solution and inhibits aggregation to beta-hematin at pH approximately 5 to a slightly lower extent than chloroquine diphosphate; more importantly, the heme aggregation inhibition activity of complex 1 is significantly higher than that of CQ when measured at the interface of n-octanol-aqueous acetate buffer mixtures under acidic conditions modeling the food vacuole of the parasite. Partition coefficient measurements confirmed that complex 1 is considerably more lipophilic than CQ in n-octanol-water mixtures at pH approximately 5. This suggests that the principal target of complex 1 is the heme aggregation process, which has recently been reported to be fast and spontaneous at or near water-lipid interfaces. The enhanced antimalarial activity of complex 1 is thus probably due to a higher effective concentration of the drug at or near the interface compared with that of CQ, which accumulates strongly in the aqueous regions of the vacuole under those conditions. Furthermore, the activity of complex 1 against CQ-resistant strains of P. falciparum is probably related to its greater lipophilicity, in line with previous reports indicating a lowered ability of the mutated transmembrane transporter PfCRT to promote the efflux of highly lipophilic drugs. The metal complex also interacts with DNA by intercalation, to a comparable extent and in a similar manner to uncomplexed CQ and therefore DNA binding does not appear to be an important part of the mechanism of antimalarial action in this case.     

Chromium-cage complex as contrast agent in MR imaging—Biodistribution studies of the [57Co]cobalt analogue

The synthesis and T₁ and T₂ relaxivities of the Cr(III)-(NH₂)-Sar-cage complex is reported. An outer-sphere relaxation mechanism is postulated for the relaxivity of the complex. Tissue distribution studies in mice using a [⁵⁷Co]cobalt analogue as a radioactive tracer showed that the complex is excreted rapidly in the urine. Some renal uptake of the complex is seen. Appreciable uptake of labelled cage complex was observed in 3-methylcholanthrene induced murine rhabdomyosarcoma.     

The photolytic release of copper from the copper penicillamine complex [Cu(II)6Cu(I)8(D-penicillamine)12Cl]5−

The light sensitivity of CuPen ([Cu(II)₆Cu(I)₈(D-penicillamine)₁₂Cl]⁵⁻ was examined. The wavelength range of the photolytic activity was determined in the visible and near-ultraviolet region of the electromagnetic spectrum. No photolytic activity was observed above 450 nm. The quantum yield of copper release was measured between 450 nm and 250 nm and was found to increase from 0 to 0.1. A shoulder around 400 nm corresponding to electronic absorption and CD features was observed in the photo-action spectrum. Inhibition of formazan formation from nitroblue tetrazolium mediated by xanthine oxidase-generated superoxide was used to quantify the copper release as a result of the photolytic decomposition of CuPen. The influence of oxygen on the photolytic reaction was investigated by EPR and electronic absorption spectroscopy. In the absence of oxygen, visible light induces almost total bleaching. However, EPR reveals only slight changes in the spin concentration. Upon introduction of aerobic EDTA all of the copper is immediately oxidised to Cu(II).     

The Q-cycle reviewed: How well does a monomeric mechanism of the bc(1) complex account for the function of a dimeric complex?

Recent progress in understanding the Q-cycle mechanism of the bc(1) complex is reviewed. The data strongly support a mechanism in which the Q(o)-site operates through a reaction in which the first electron transfer from ubiquinol to the oxidized iron-sulfur protein is the rate-determining step for the overall process. The reaction involves a proton-coupled electron transfer down a hydrogen bond between the ubiquinol and a histidine ligand of the [2Fe-2S] cluster, in which the unfavorable protonic configuration contributes a substantial part of the activation barrier. The reaction is endergonic, and the products are an unstable ubisemiquinone at the Q(o)-site, and the reduced iron-sulfur protein, the extrinsic mobile domain of which is now free to dissociate and move away from the site to deliver an electron to cyt c(1) and liberate the H(+). When oxidation of the semiquinone is prevented, it participates in bypass reactions, including superoxide generation if O(2) is available. When the b-heme chain is available as an acceptor, the semiquinone is oxidized in a process in which the proton is passed to the glutamate of the conserved -PEWY- sequence, and the semiquinone anion passes its electron to heme b(L) to form the product ubiquinone. The rate is rapid compared to the limiting reaction, and would require movement of the semiquinone closer to heme b(L) to enhance the rate constant. The acceptor reactions at the Q(i)-site are still controversial, but likely involve a "two-electron gate" in which a stable semiquinone stores an electron. Possible mechanisms to explain the cyt b(150) phenomenon are discussed, and the information from pulsed-EPR studies about the structure of the intermediate state is reviewed. The mechanism discussed is applicable to a monomeric bc(1) complex. We discuss evidence in the literature that has been interpreted as shown that the dimeric structure participates in a more complicated mechanism involving electron transfer across the dimer interface. We show from myxothiazol titrations and mutational analysis of Tyr-199, which is at the interface between monomers, that no such inter-monomer electron transfer is detected at the level of the b(L) hemes. We show from analysis of strains with mutations at Asn-221 that there are coulombic interactions between the b-hemes in a monomer. The data can also be interpreted as showing similar coulombic interaction across the dimer interface, and we discuss mechanistic implications.     

New μ-Oxo-heterobinuclear complex containing the FeOSi linkage: Synthesis and structural characterization of [FeSALEN] OSi(CH3)3

The reaction of hexamethyldisilazane with the μ-oxo iron SALEN dimer in toluene under N₂ gives the μ-heterobinuclear title complex, FeC₁₉H₂₃N₂0₃Si. Crystals of the compound are monoclinic, space group P2₁/c with a = 6.087(2), b = 10.497(3), c = 28.567(7) Å, β = 97.78(2) and Z = 4. Solution of the structure by direct methods led to a final weighted and unweighted R factors of 6.2 and 5.6%, respectively. The coordination geometry of the iron center is square-pyramidal with the iron displaced 0.56 Å from the best least-squares plane of the coordinating oxygens and nitrogens of the SALEN ligand. The FeOSi angle is bent at 142.7°. The FeOSi linkage does not hydrolyze under neutral pH conditions.     

Synthesis and structure of the complex tetra-μ-prolinatodirhodium(II)

The dinuclear Rh^IIRh^II complex with proline [Rh₂(pro₄][NEt₄]₂ was synthesized and its structure studied by means of spectroscopic (IR, EPR and ESCA) and magnetochemical methods. It was shown that two proline molecules serve as bridging ligands, while the other two are only axially coordinated through their N atoms.     

X-ray structure of dimeric [Co(poph)(NCS)2]2, an N-oxide-bridged cobalt(II) complex with 2-pyridinecarboxaldehyde 1-oxide 2′-pyridinylhydrazone (poph)

An X-ray structure determination is reported for the N-oxide-bridged dimeric complex [Co(poph)- (NCS)₂]₂ with 2-pyridinecarboxaldehyde 1-oxide 2′-pyridinylhydrazone (poph). The complex is monoclinic, P2₁/c, with a = 12.460(7), b = 9.884(3), c = 16.562(8) Å, β= 127.60(2)° and Z = 4. The ligand coordinates as a planar ONN tridentate via the N-oxide oxygen and the hydrazone and pyridyl nitrogens. A second out-of-ligand-plane bond from the N-oxide oxygen to another cobalt produces a centrosymmetric N-oxide-bridged structure. The in-ligand and out-of-ligand-plane CoO distances are 2.028(5) and 2.460(5) Å, respectively. Each cobalt(II) is octahedrally coordinated by two cisN- bonded thiocyanates, by an ONN-bonded poph molecule, and by a bridging N-oxide oxygen. This is the first structure report of a pyridine N-oxide. bridged cobalt(II) complex.     

A procedure for the synthesis of p-fluorosulfonyl[14C]-benzoyl-5′-adenosine with [14C] in the benzoyl moiety

Carboxy-p-fluorosulfonyl[¹⁴C]benzoyl-5′-adenosine has been synthesized with the radiolabel ultimately derived from carboxy-p-amino[¹⁴C]benzoic acid by a synthetic route employing four reaction steps. Starting with 1 mmol of p-amino[¹⁴C]benzoic acid, p-fluorosulfonyl[¹⁴C]benzoyl-5′-adenosine is obtained with an overall yield of 25–30%.     

Apoptotic effects of dipyrido [3,2-a:2′,3′-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats

We evaluated the effects of dipyrido [3,2-a:2′,3′-c] phenazine (dppz) Au(III) complex ([Au(dppz)Cl₂]Cl) on apoptosis during chemically induced hepatocellular carcinoma. 48 male Spraque-Dawley rats were divided into six groups; group I (control), group II [Dimethyl sulfoxide (DMSO)], group III ([Au(dppz)Cl₂]Cl), group IV [diethylnitrosamine + Phenobabital (DEN + PB)], group V (DEN + PB + [Au(dppz)Cl₂]Cl (2nd week)), and group VI (DEN + PB + [Au(dppz)Cl₂]Cl (7th week). The rats in groups IV through VI were administrated with DEN in a single dose of intraperitoneal 175 mg/kg. After 2 weeks of DEN administration, these groups of rats were given daily PB in a dose of 500 ppm. In group V, after two weeks of DEN administration, [Au(dppz)Cl₂]Cl complex (2 mg/kg) was given once a week by intraperitoneal injection. In the group VI, the rats were given a dose of 2 mg/kg [Au(dppz)Cl₂]Cl complex once a week, 7 weeks after DEN administration. At the end of the study, blood and tissue samples were collected from the rats to determine levels of serum AST, ALT, and LDH, and caspase 3, p53, Bax, Bcl-2 and DNA fragmentation in liver. AST, ALT, LDH, and Bcl-2 levels were higher in group IV, compared to group I, but caspase 3 and p53 levels were lower. In group V, caspase 3, p53, Bax, and DNA fragmentation levels were higher than those of group IV. Caspase 3 and p53 levels increased in group VI compared with group IV. In conclusion, [Au(dppz)Cl₂]Cl complex induced apoptosis by elevating levels of caspase 3, p53, Bax, and DNA fragmentation.     

The conversion of 4-hydroxypyrazolo-[3,4-d]pyrimidine (allopurinol) into 4,6-dihydroxypyrazolo[3,4-d]pyrimidine (oxipurinol) in vivo in the absence of xanthine–oxygen oxidoreductase

1. A patient with congenital deficiency of xanthine oxidase (EC 1.2.3.2) (xanthinuria) excreted the xanthine isomer 4,6-dihydroxypyrazolo[3,4-d]pyrimidine (oxipurinol) in his urine when the hypoxanthine isomer 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) was given by mouth. 2. The identity of the oxipurinol that the patient excreted was established by mass spectrometry. 3. The mass spectra and infrared spectra of allopurinol, oxipurinol, hypoxanthine and xanthine are compared. 4. A mechanism for the fragmentation of these compounds that occurs during their mass-spectrometric investigation is proposed. 5. A possible metabolic pathway for the oxidation of allopurinol to oxipurinol in the absence of xanthine oxidase is discussed.     

Additional characterization of the two oxygen-containing compounds formed by the interaction of phthalocyaninatoiron(II) and dioxygen. Reproducible synthesis of the species isomorphic with the α form of Fe(II)Pc

The two compounds obtained by the interaction in solution of Fe(lI)Pc with O₂, presently considered two crystalline modifications of the μ-oxo dimer of Fe(III)Pc, are further characterized by visible absorption, XPS and Mössbauer spectra. The results stress the difference between the solid state properties of the two Fe(III) compounds.The behaviour of Fe(II)Pc and the two oxidized compounds in some chlorinated and non-chlorinated solvents, at different temperatures in the presence and absence of O₂, is reported. It is seen that heating the two Fe(III) products in 1-chloronaphthalene, or dimethylformamide, in vacuum sealed tubes, gives as a final product βFe(II)Pc. However, the same procedure in chlorobenzene or nitrobenzene yields, in a reproducible way, the pure oxygen-containing species which is isomorphic with αFe(II)Pc. Until now this product was only obtained in a fortuitous manner.     

Reactions of thiols and selenols with the FeMoS cluster [Fe(MoS4)2]3−

The known complex [Et₄N]₃[Fe(MoS₄)₂] has been shown by EPR and visible spectral studies to react with both thiophenol and selenophenol. The reaction results in a change in the characteristic S=3/2 EPR spectrum of this species from a complex rhombic pattern to one of a very simple axial appearance. Although this effect is similar to that observed for reaction of these species with the iron- molybdenum cofactor of nitrogenase, a moiety known to consist of a FeMoS cluster species, the large excesses of reagents and the long reaction times required for complete formation of product indicate that these reactions are of questionable direct relevance to the biological system. The reaction corresponding to the EPR spectral change from rhombic to axial in the [Fe(MoS₄)₂]³⁻/PhSeH system has also been partially characterized by product isolation which indicates that attack by selenol of the two terminal MoS₂ moieties in the starting material has occurred.     

Nucleophilic addition and various species formed in the Cu(II)NCO−3(5)-methylpyrazole system

From the Cu(II)NCO⁻3(5)-methylpyrazole (mpz) system two compounds Cu(NCO)₂(mpz)₂ and four compounds Cu(mpz·NCO)₂ were isolated. The latter compounds contain carbamoylmethylpyrazolate anions as chelate ligands and are coligand isomers of the cyanate compounds. According to the results of indirect structural methods, the Cu(NCO)₂(mpz)₂ complexes have pseudooctahedral structures and differ in their polyhedron distortions. The Cu(mpz·NCO)₂ complexes show tetragonally distorted six or five coordinate structures, possibly differing also by the methyl group position on the pyrazole ring.     

MonodentateN coordination of 1aza4oxo1,3butadienes [R1NC(R2)C(R3)O] to platinum(II). X-ray structure of trans-[PtCl2(PEt3){σ-N-(t-BuNCHC(Me)O)}]

Reaction of dimeric trans-[PtCl₂(PR₃)]₂ with 1-aza-4-oxo-1,3-butadienes [R¹NC(R²)C(R³)O, R³ = Me, Ph, OMe, NEt₂] in a 1:2 molar ratio results in almost quantitative formation of mononuclear complexes trans·[PtCl₂(PR₃){σ-N-(R¹NC(R²)C(R³)O)}]. The ligands are bonded in the monodentate σ-N bonding mode to the platinum(II) centre. This has been established by an X-ray structure determination of trans-[PtCl₂(PEt₃){σ-N-(t-BuNCHC(Me)O)}]. Crystals of the latter compound are orthorhombic with space group Pc2₁n; cell constants are a = 14.712(3), b = 15.053(2), c = 9.025(5) Å, Z= 4 and R_w = 0.056 for 3281 reflections. The 1aza4oxol,3butadiene (α-iminoketone for R³ is alkyl or aryl) has the E-configuration about the imine bond (CN 1.34(4) Å), with a C(5)C(6) distance of 1.44(5) Å and a NC(5)/ C(6)O torsion angle of 89(4)°. As a result of this ligand conformation, the acetyl hydrogen atoms are positioned (on average) into the neighbourhood of the Pt-atom above the Pt-coordination plane. Infrared and NMR (¹H, ¹³C, ³¹p) data show that these structural features are also predominant in solution.     

The Q-cycle reviewed: How well does a monomeric mechanism of the bc1 complex account for the function of a dimeric complex?

Recent progress in understanding the Q-cycle mechanism of the bc₁ complex is reviewed. The data strongly support a mechanism in which the Q_o-site operates through a reaction in which the first electron transfer from ubiquinol to the oxidized iron–sulfur protein is the rate-determining step for the overall process. The reaction involves a proton-coupled electron transfer down a hydrogen bond between the ubiquinol and a histidine ligand of the [2Fe–2S] cluster, in which the unfavorable protonic configuration contributes a substantial part of the activation barrier. The reaction is endergonic, and the products are an unstable ubisemiquinone at the Q_o-site, and the reduced iron–sulfur protein, the extrinsic mobile domain of which is now free to dissociate and move away from the site to deliver an electron to cyt c₁ and liberate the H⁺. When oxidation of the semiquinone is prevented, it participates in bypass reactions, including superoxide generation if O₂ is available. When the b-heme chain is available as an acceptor, the semiquinone is oxidized in a process in which the proton is passed to the glutamate of the conserved -PEWY- sequence, and the semiquinone anion passes its electron to heme b_L to form the product ubiquinone. The rate is rapid compared to the limiting reaction, and would require movement of the semiquinone closer to heme b_L to enhance the rate constant. The acceptor reactions at the Q_i-site are still controversial, but likely involve a “two-electron gate” in which a stable semiquinone stores an electron. Possible mechanisms to explain the cyt b₁₅₀ phenomenon are discussed, and the information from pulsed-EPR studies about the structure of the intermediate state is reviewed.The mechanism discussed is applicable to a monomeric bc₁ complex. We discuss evidence in the literature that has been interpreted as shown that the dimeric structure participates in a more complicated mechanism involving electron transfer across the dimer interface. We show from myxothiazol titrations and mutational analysis of Tyr-199, which is at the interface between monomers, that no such inter-monomer electron transfer is detected at the level of the b_L hemes. We show from analysis of strains with mutations at Asn-221 that there are coulombic interactions between the b-hemes in a monomer. The data can also be interpreted as showing similar coulombic interaction across the dimer interface, and we discuss mechanistic implications.     

The crystal and molecular structures of dichlorobis (5,7-diphenyl-1,2,4-triazolo[1,5-α]pyrimidine)zinc(II) (1) and dichlorobis(5,7-diphenyl-1,2,4-triazolo[1,5-α]pyrimidine)cobalt(II) (2)

The synthesis and structural studies of the new ligand 5,7-diphenyl-1,2,4-triazolo[1,5-α]pyrimidine (dptp), which can be considered as an analog of purine, and its complexes are described. Complexes were characterised by spectral measurements (IR, NMR, UV-Vis). In addition X-ray structural analysis was performed. Crystals of [Zn(C₁₇H₁₂N₄)₂Cl₂] (1) revealed the following parameters: M_r = 680.9; monoclinic for 2188 observed reflections. [Co(C₁₇H₁₂N₄)₂Cl₂] (2); M_r = 674.4; monoclinic for 1630 observed reflections.     

The structural stabilization of the κ three-way junction by Mg(II) represents the first step in the folding of a group II intron

Folding of group II introns is characterized by a first slow compaction of domain 1 (D1) followed by the rapid docking of other domains to this scaffold. D1 compaction initiates in a small subregion encompassing the κ and ζ elements. These two tertiary elements are also the major interaction sites with domain 5 to form the catalytic core. Here, we provide the first characterization of the structure adopted at an early folding step and show that the folding control element can be narrowed down to the three-way junction with the κ motif. In our nuclear magnetic resonance studies of this substructure derived from the yeast mitochondrial group II intron Sc.ai5γ, we show that a high affinity Mg(II) ion stabilizes the κ element and enables coaxial stacking between helices d′ and d′′, favoring a rigid duplex across the three-way junction. The κ-element folds into a stable GAAA-tetraloop motif and engages in A-minor interactions with helix d′. The addition of cobalt(III)hexammine reveals three distinct binding sites. The Mg(II)-promoted structural rearrangement and rigidification of the D1 core can be identified as the first micro-step of D1 folding.     

Structural and some medicinal characteristics of the copper(II)–hydroxychloroquine complex

In the first phase of this study, the binding of hydroxychloroquine to the copper(II) cation is examined using liquid chromatography–mass spectrometry (LC–MS), matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS), Fourier transform-ion cyclotron resonance spectrometry (FT-ICR) and nuclear magnetic resonance (¹H and ¹³C NMR) in one and two dimensions. The data suggest the metal–ligand complex is a polarity adaptive molecule. In the second phase of the study, the complexes activity is tested against the National Cancer Institute’s 60 cell line panel. Its anti-cancer activity is compared to quinine, Cu(II)–quinine and hydroxychloroquine. It serves as a base line for future anti-cancer complexes in which hydroxychloroquine is utilized for its ability to impact cell autophagy.